healthcare organization
Mater Health Services
AU
People
Connected researchers
Public evidence
6 connected articles
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMCQuality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis.2023 · Europe PMCExploring potential anti-inflammatory effects of medicinal cannabis.2023 · PubMed Central Open Access'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.2022 · PubMed Central Open AccessUsing a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.2022 · PubMed Central Open AccessOral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).2019 · Europe PMC
Matched by exact identifiers only. Profile data: OpenAlex.